.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Federal Trade Commission
Daiichi Sankyo
Harvard Business School
Teva
US Department of Justice
Baxter
Moodys
Healthtrust
Mallinckrodt

Generated: December 16, 2017

DrugPatentWatch Database Preview

SPORANOX Drug Profile

« Back to Dashboard

Which patents cover Sporanox, and what generic alternatives are available?

Sporanox is a drug marketed by Janssen Pharms and is included in three NDAs. There is one patent protecting this drug and one Paragraph IV challenge.

The generic ingredient in SPORANOX is itraconazole. There are fifteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the itraconazole profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen PharmsSPORANOXitraconazoleCAPSULE;ORAL020083-001Sep 11, 1992ABRXYesYes► Subscribe► Subscribe► Subscribe
Janssen PharmsSPORANOXitraconazoleINJECTABLE;INJECTION020966-001Mar 30, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
Janssen PharmsSPORANOXitraconazoleSOLUTION;ORAL020657-001Feb 21, 1997RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: SPORANOX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen PharmsSPORANOXitraconazoleSOLUTION;ORAL020657-001Feb 21, 1997► Subscribe► Subscribe
Janssen PharmsSPORANOXitraconazoleCAPSULE;ORAL020083-001Sep 11, 1992► Subscribe► Subscribe
Janssen PharmsSPORANOXitraconazoleSOLUTION;ORAL020657-001Feb 21, 1997► Subscribe► Subscribe
Janssen PharmsSPORANOXitraconazoleSOLUTION;ORAL020657-001Feb 21, 1997► Subscribe► Subscribe
Janssen PharmsSPORANOXitraconazoleINJECTABLE;INJECTION020966-001Mar 30, 1999► Subscribe► Subscribe
Janssen PharmsSPORANOXitraconazoleINJECTABLE;INJECTION020966-001Mar 30, 1999► Subscribe► Subscribe
Janssen PharmsSPORANOXitraconazoleSOLUTION;ORAL020657-001Feb 21, 1997► Subscribe► Subscribe
Janssen PharmsSPORANOXitraconazoleINJECTABLE;INJECTION020966-001Mar 30, 1999► Subscribe► Subscribe
Janssen PharmsSPORANOXitraconazoleCAPSULE;ORAL020083-001Sep 11, 1992► Subscribe► Subscribe
Janssen PharmsSPORANOXitraconazoleCAPSULE;ORAL020083-001Sep 11, 1992► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for SPORANOX

Drugname Dosage Strength RLD Submissiondate
itraconazoleOral Solution10 mg/mLSporanox5/3/2013

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
AstraZeneca
McKesson
Cipla
Chubb
Mallinckrodt
Cerilliant
Citi
Dow
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot